These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27800187)

  • 21. Thrombocytopenia in Chronic Liver Disease: Challenges and Treatment Strategies.
    Desai S; Subramanian A
    Cureus; 2021 Jul; 13(7):e16342. PubMed ID: 34277309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures.
    Gallo P; Terracciani F; Di Pasquale G; Esposito M; Picardi A; Vespasiani-Gentilucci U
    World J Gastroenterol; 2022 Aug; 28(30):4061-4074. PubMed ID: 36157107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase 2 study of avatrombopag in Japanese patients with chronic liver disease and thrombocytopenia.
    Eguchi Y; Takahashi H; Mappa S; Santagostino E
    Hepatol Res; 2022 Apr; 52(4):371-380. PubMed ID: 35134259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: a treatment algorithm for patients with chronic liver disease and severe thrombocytopenia undergoing elective medical procedures in the United States.
    Dieterich DT; Bernstein D; Flamm S; Pockros PJ; Reau N
    Aliment Pharmacol Ther; 2020 Oct; 52(8):1311-1322. PubMed ID: 32813292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic liver disease, thrombocytopenia and procedural bleeding risk; are novel thrombopoietin mimetics the solution?
    Olson SR; Koprowski S; Hum J; McCarty OJT; DeLoughery TG; Shatzel JJ
    Platelets; 2019; 30(6):796-798. PubMed ID: 30422039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag.
    Tarantino MD; Fogarty PF; Shah P; Brainsky A
    Platelets; 2015; 26(1):93-6. PubMed ID: 24433306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombocytopenia in Chronic Liver Disease: New Management Strategies.
    Nilles KM; Flamm SL
    Clin Liver Dis; 2020 Aug; 24(3):437-451. PubMed ID: 32620282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.
    Maan R; de Knegt RJ; Veldt BJ
    Drugs; 2015 Nov; 75(17):1981-92. PubMed ID: 26501978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.
    Danish FI; Yasmin S
    Hepat Med; 2013; 5():17-30. PubMed ID: 24696622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.
    Al-Jafar H; Giagounidis A; El-Rashaid K; Al-Ali M; Hakim AA
    Ann Pharmacother; 2012 Nov; 46(11):e31. PubMed ID: 23115229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis.
    Lindquist I; Olson SR; Li A; Al-Samkari H; Jou JH; McCarty OJT; Shatzel JJ
    Platelets; 2022 Jan; 33(1):66-72. PubMed ID: 33459573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management.
    Scharf RE
    J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study.
    Nomoto H; Morimoto N; Miura K; Watanabe S; Takaoka Y; Maeda H; Sasaki T; Koyashiki Y; Kurata H; Numao N; Isoda N; Yamamoto H
    BMC Gastroenterol; 2020 Dec; 20(1):427. PubMed ID: 33317473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases.
    Kawaguchi T; Nakano M; Satani M; Sumie S; Yamada S; Amano K; Kuromatsu R; Sata M
    Oncol Lett; 2014 Jun; 7(6):2130-2134. PubMed ID: 24932302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges.
    Huang A; Chen JF; Wu JZ; Gao Z; Shi YH; Fu XT; Zhang X; Liu WR; Gao Q; Sun HC; Shi GM; Fan J; Ding ZB; Zhou J
    J Oncol; 2022; 2022():9138195. PubMed ID: 36405248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade?
    van Dievoet MA; Eeckhoudt S; Stephenne X
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2).
    Peck-Radosavljevic M; Simon K; Iacobellis A; Hassanein T; Kayali Z; Tran A; Makara M; Ben Ari Z; Braun M; Mitrut P; Yang SS; Akdogan M; Pirisi M; Duggal A; Ochiai T; Motomiya T; Kano T; Nagata T; Afdhal N
    Hepatology; 2019 Oct; 70(4):1336-1348. PubMed ID: 30762895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies.
    Poordad F; Terrault NA; Alkhouri N; Tian W; Allen LF; Rabinovitz M
    Int J Hepatol; 2020; 2020():5421632. PubMed ID: 32047671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis.
    Moussa MM; Mowafy N
    J Gastroenterol Hepatol; 2013 Feb; 28(2):335-41. PubMed ID: 22849409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures.
    Katsube T; Shimizu R; Fukuhara T; Kano T; Wajima T
    Clin Pharmacokinet; 2019 Nov; 58(11):1469-1482. PubMed ID: 31055790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.